BBVA USA’s Zoetis ZTS Stock Holding History

BBVA USA’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$95K	Sell	490 -139	-22%	-$28.1K	0.01%	549
2021 Q2	$117K	Buy	+629	New	+$109K	0.01%	539

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BBVA USA's ZTS Position: Q3 2021 in Review

BBVA USA reduced its Zoetis (ZTS) stake by 22% in Q3 2021, selling an estimated $28.1K and leaving 490 shares worth $95K. The position accounts for 0.01% of the portfolio, ranked #549.

BBVA USA first reported a position in ZTS in Q2 2021 and has held it in 2 quarters since. The position peaked at $117K in Q2 2021. 1,477 funds tracked by Wall St. Rank hold ZTS as of Q3 2021.

BBVA USA held 490 shares of Zoetis worth $95K as of Q3 2021.
BBVA USA sold 139 Zoetis shares in Q3 2021, an estimated $28.1K.
Zoetis made up 0.01% of BBVA USA's portfolio in Q3 2021, its #549 holding.
BBVA USA first reported a position in Zoetis in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Zoetis position peaked at $117K in Q2 2021.
1,477 funds tracked by Wall St. Rank held Zoetis as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.